Replies to post #5435 on Enanta Pharmaceuticals Inc (ENTA)

[dewophile]

trading at cash plus NPV royalty more or less - i.e. factoring in virtually nothing for RSV assets (or immunology but that is super early)
so while this is great and all, this could be headed quite a bit higher IMO. Rome wasn't built in a day


edit: I sold half and am holding onto the other for the longer term